Hims & Hers Health Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Hims & Hers Health stock has a consensus rating of "Hold" and an average price target of $31.23. The average 1-year stock price forecast is 3.86% higher than the current stock price, while the lowest is $23 (-23.51%) and the highest is $42 (+39.67%).

Price Target: $31.23 (+3.86%)

Analyst Consensus: Hold

Price Target

Chart

Target	Low	Average	Median	High
Price	$23	$31.23	$31	$42
Change	-23.51%	+3.86%	+3.09%	+39.67%

Analyst Ratings

The average analyst rating for Hims & Hers Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	1	1	1	1	1	1
Buy	2	3	3	2	2	2
Hold	12	12	12	11	12	11
Sell	0	0	0	1	0	1
Strong Sell	0	0	0	0	0	0
Total	15	16	16	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jailendra Singh Truist Financial	Truist Financial	Hold Reiterates $27 → $32	Hold	Reiterates	$27 → $32	+6.42%	Aug 24, 2026
Glen Santangelo Barclays	Barclays	Buy Reiterates $39 → $35	Buy	Reiterates	$39 → $35	+16.40%	Aug 21, 2026
George Hill Deutsche Bank	Deutsche Bank	Hold Reiterates $25 → $26	Hold	Reiterates	$25 → $26	-13.54%	Aug 11, 2026
Jonna Kim TD Cowen	TD Cowen	Hold Reiterates $25 → $30	Hold	Reiterates	$25 → $30	-0.23%	Aug 11, 2026
Craig Hettenbach Morgan Stanley	Morgan Stanley	Hold Reiterates $21 → $28	Hold	Reiterates	$21 → $28	-6.88%	Aug 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

3.20B

from 2.35B

36.38%

from 2.35B

Revenue Next Year

3.98B

from 3.20B

24.32%

from 3.20B

EPS This Year

0.54

from 1.10

-51.24%

from 1.10

EPS Next Year

1.11

from 0.54

107.41%

from 0.54

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	271.88M	526.92M	872.00M	1.48B	2.35B	3.20B
Revenue Growth	82.77%	93.81%	65.49%	69.33%	59.00%	36.38%
Gross Profit	204.49M	408.72M	714.95M	1.17B	1.73B	2.11B
Gross Margin	75.22%	77.57%	81.99%	79.45%	73.84%	65.95%
Operating Income	-106.94M	-66.38M	-26.44M	65.88M	121.16M	-87.78M
Net Income	-107.66M	-65.68M	-23.55M	126.04M	128.37M	-114.43M
EPS	-	-	-	-	1.10	0.54
EPS Growth	-	-	-	-	16.23%	-51.24%
Forward PE	-	-	-	47.31	55.10	55.97
Free Cash Flow	52.46M	-44.35M	66.38M	178.62M	110.51M	96.66M
No. Analysts	-	-	-	-	-	14

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	3.3B
Avg	3.2B
Low	3.1B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	40.9%
Avg	36.4%
Low	33.7%

EPS Forecast

Chart

EPS	2026	2027	2028
High	0.75
Avg	0.54
Low	0.17

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-32.0%
Avg	-51.2%
Low	-84.6%